ESH/LinkedIn
Mar 3, 2026, 15:16
Transplant vs CAR T Cells in Multiple Myeloma Debate at ESHMM 2026 – ESH
European School of Haematology (ESH) shared a post on LinkedIn:
“Programme Highlight of ESHMM 2026!
Debate 3 – Transplant vs CAR T cells.
Moderated by Martin Kaiser with Mohamad Mohty and Robert Orlowski (with audience voting)
Less than a month to go before the conference begins!
Secure your spot today — Register now and Join us on March 26-28, 2026 in Stockholm, Sweden.
8th Translational Research Conference on Multiple Myeloma.
Conference Chairs: Hartmut Goldschmidt, Martin Kaiser, Suzanne Lentzsch”
Stay updated with Hemostasis Today.
-
Jul 24, 2026, 03:57Balvinder Bobbie Saarsalu: Hemostatic Biomarkers in Acute Myeloid Leukemia
-
Jul 24, 2026, 03:49Fateme Babaha: Pleasure to Present A Novel FVIII Gene Therapy Enhancer at ISTH 2026
-
Jul 24, 2026, 03:44Manabu Inoue: Tenecteplase or Alteplase Before Thrombectomy by T-FLAVOR Trial
-
Jul 24, 2026, 03:36We Received The AHA Get With The Guidelines Stroke Gold Plus Quality Achievement Award – Lakeland Regional Health-Florida
-
Jul 24, 2026, 03:31Ana Catarina Fonseca: The Persistent Gaps in Blood Pressure Guideline Achievement After Stroke
-
Jul 24, 2026, 03:30Mapillar Dahn: Pursuing Education While Living With Sickle Cell Disease
-
Jul 24, 2026, 03:22Get to Know Frits Rosendaal, The 2026 Grant Medal Recipient – ISTH
-
Jul 24, 2026, 03:15Edward Lee Carter: Anticoagulation Is Not a Prescription – It’s a Longitudinal Clinical Decision
-
Jul 24, 2026, 03:06Rebekah Bradford: A More Affordable Option for Xarelto